Penumbra, Inc. to Present at the 34th Annual J.P. Morgan 2016 Healthcare Conference

December 28, 2015
ALAMEDA, Calif., Dec. 28, 2015 — Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that its management team is scheduled to present at the 34th Annual J.P. Morgan 2016 Healthcare Conference in San Francisco, CA at the Westin St. Francis Hotel.

Event: 34th Annual J.P. Morgan 2016 Healthcare Conference
Date: Tuesday, January 12, 2016
Time: 11:00 am PT / 2:00 pm ET

A webcast of the presentation can be accessed on the “Investors” section of the Company's website at: The webcast will be available on the Company's website for two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

Sara Thompson
Head of Investor Relations
Penumbra, Inc.
510 995 2455

SOURCE Penumbra, Inc.


Contact us to learn more about our products and company